Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis

Mads Ravnborg, K Bendtzen, O Christensen, P E H Jensen, D Hesse, M G Tovey, P S Sørensen

21 Citationer (Scopus)

Abstract

It is unknown whether immunosuppression of patients who have developed interferon-beta (IFN-beta) neutralizing antibodies (NAbs) hastens disappearance of NAbs in the blood.
OriginalsprogEngelsk
TidsskriftMultiple Sclerosis
Vol/bind15
Udgave nummer3
Sider (fra-til)323-8
Antal sider6
ISSN1352-4585
DOI
StatusUdgivet - 1 mar. 2009

Fingeraftryk

Dyk ned i forskningsemnerne om 'Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis'. Sammen danner de et unikt fingeraftryk.

Citationsformater